Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of PAVmed Inc (NASDAQ: PAVM) was $0.22 for the day, down -6.44% from the previous closing price of $0.24. In other words, the price has decreased by -$6.44 from its previous closing price. On the day, 1.19 million shares were traded. PAVM stock price reached its highest trading level at $0.255 during the session, while it also had its lowest trading level at $0.21.
Ratios:
Our analysis of PAVM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.40. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on March 30, 2021, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 05, 2020, Ascendiant Capital Markets started tracking the stock assigning a Buy rating and target price of $5.
On June 28, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.Maxim Group initiated its Buy rating on June 28, 2018, with a $5 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PAVM now has a Market Capitalization of 204335 and an Enterprise Value of 29351590. For the stock, the TTM Price-to-Sale (P/S) ratio is 218.33 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 1012.124 whereas that against EBITDA is -1.465.
Stock Price History:
The Beta on a monthly basis for PAVM is 1.09, which has changed by -0.6719168 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, PAVM has reached a high of $0.89, while it has fallen to a 52-week low of $0.21. The 50-Day Moving Average of the stock is -36.95%, while the 200-Day Moving Average is calculated to be -58.00%.
Shares Statistics:
PAVM traded an average of 562.35K shares per day over the past three months and 21997 shares per day over the past ten days. A total of 29.67M shares are outstanding, with a floating share count of 25.01M. Insiders hold about 15.70% of the company’s shares, while institutions hold 8.78% stake in the company. Shares short for PAVM as of 1765756800 were 14243 with a Short Ratio of 0.76, compared to 1763078400 on 16036. Therefore, it implies a Short% of Shares Outstanding of 14243 and a Short% of Float of 1.67.
Earnings Estimates
. The current assessment of PAVmed Inc (PAVM) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$4.2, with high estimates of -$4.2 and low estimates of -$4.2.
Analysts are recommending an EPS of between -$9.6 and -$9.6 for the fiscal current year, implying an average EPS of -$9.6. EPS for the following year is -$17.1, with 1.0 analysts recommending between -$17.1 and -$17.1.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $74k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $48k.
Based on 2 analysts’ estimates, the company’s revenue will be $490k in the next fiscal year. The high estimate is $500k and the low estimate is $480k.
